| GPRO 1.23 40.38% | PCG 14.06 5.95% | LIDR 1.47 27.83% | NVDA 217.44 -1.51% | HKPD 0.1815 -45.54% | TSLL 9.33 -6.42% | NVD 4.05 3.05% | RITR 0.0882 -4.13% | NIO 4.055 -4.14% | FLYE 2.2 61.76% | INTC 88.97 -0.60% | ONDS 7.04 -8.05% | NU 14.46 -0.62% | BITO 10.38 -2.35% | RZLV 2.39 -17.30% | PATH 18.14 -2.84% | SOXL 105.91 -6.10% | AAL 12.95 -3.57% | NOK 9.93 -2.07% | TQQQ 69.15 -3.85% | SPCX 142.23 -1.02% | AAPL 325.13 2.61% | IBIT 43.76 -2.04% | F 13.83 -0.79% | HYG 79.1 -0.89% | SQQQ 39.97 3.79% | PLUG 2.09 -3.24% | SOXS 52.22 6.53% | BIAF 6.59 44.52% | SGOV 100.41 -0.28% | BTG 5.2 -5.11% | CDE 20.2 -2.79% | QID 14.59 2.53% | SOFI 17.05 -4.64% | PFE 28.55 0.32% | SPY 761.78 -0.69% | BMNR 23.37 -7.70% | GRAB 3.46 -2.26% | AIM 0.236 4.42% | RIG 5.92 1.89% | TSLA 356.09 -3.22% | FRVO 19.75 28.41% | LQD 105.22 -0.93% | QQQ 707.64 -1.27% | SSM 4.755 77.43% | IREN 36.82 -0.79% | ETHA 18.23 -2.62% | XLE 64.77 1.27% | T 26.015 0.48% | EWZ 36.57 1.50%

Tenet Healthcare Corporation (NYSE:THC) Price Target Raised Amid Strong Analyst Sentiment

Tenet Healthcare Corporation is a Dallas-based company that operates a large network of hospitals and outpatient centers. With a market capitalization of approximately $17.50 billion, it is a major entity within the healthcare services industry. The company's performance is often watched closely by investors tracking the broader medical sector.

An analyst from Wells Fargo, Stephen Baxter, has raised the price target for Tenet Healthcare to $231.00 from a previous target of $213.00. This new forecast suggests a potential upside of about 13.10% from the stock's price of $204.25 at the time of the announcement, indicating a positive outlook on the company's future value.

This optimistic view is consistent with broader sentiment from Wall Street. As highlighted by Zacks Investment Research, Tenet Healthcare has an average brokerage recommendation of 1.39 on a scale of 1 to 5, which is between a "Strong Buy" and a "Buy". This consensus is based on ratings from 22 firms.

The positive analyst ratings are supported by the company's performance and future projections. Prior to a recent 1.22% dip, Tenet Healthcare shares had gained 19.40%, outperforming the Medical sector. Investors now anticipate its upcoming earnings, with projections for an Earnings Per Share (EPS) of $4.08 and net sales of $5.39 billion.

Year-to-date, Tenet Healthcare's shares have gained 2.60%, which contrasts with the industry's 5.50% decline. This growth is driven by expanding admissions and a strong Ambulatory Care segment. However, the company also faces a potential risk to its profit margins from rising operating expenses, which could impact future earnings.

Published on: July 13, 2026